The Christian Science Monitor recently published an article about the growing misuse of buprenorphine. Police reports of bupe-related seizures increased nationwide from 90 reports in 2003 to more than 10,500 by 2010, according to the DEA. Meanwhile, the number of emergency room visits involving bupe increased tenfold over a five-year period, reaching more than 30,000 … Continue reading Definitely not a silver bullet
Jennifer Matesa has a new piece up at the recently reincarnated The Fix. It's a response to the recent NY Times series on Suboxone and goes directly after the underlying assumption and its implications for her. Reckitt can get away with convincing doctors that addicts need to be maintained on Suboxone because—as the Times story … Continue reading we can heal
The NY Times has another article in its series on Suboxone. Buprenorphine was developed as a safer alternative to methadone for treating heroin and painkiller addiction, a take-home medication that could be prescribed by doctors in offices rather than dispensed daily in clinics. But in some areas a de facto clinic scene, unregulated, … Continue reading “a hopeless disease”
I'm a little late on posting this one, but it still seems worth sharing. Reckitt Benckiser has decided to pull Suboxone tablets from the market. Why? It's an evidence-based decision and an expression of their desire to be a good corporate citizen and their concern for children. Late last month, Reckitt Benckiser created a stir … Continue reading Suboxone Strategy: Protecting Patients Or Profits?